Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm
Project Beacon COVID-19 was started by F-Prime Capital, GV, and the Broad Institute to help implement COVID-19 testing in Massachusetts and its environs.
Eurofins' Clinical Enterprise, Ginkgo Bioworks Partner to Support COVID-19 Testing Program
Operation Expanded Testing Program is designed to provide federally funded COVID-19 testing to children in kindergarten through grade 12, as well as other groups.
Quest Diagnostics, Ginkgo Bioworks Collaborate to Provide COVID-19 Testing for Texas K-12 Schools
The companies will provide molecular COVID-19 testing for participating public, private, and charter K-12 schools for the remainder of the 2021-2022 school year.
Ginkgo Bioworks to Go Public With $1.63B in Proceeds From SPAC Merger
The company originally announced its intention to go public through the merger with Soaring Eagle in May and will begin trading on the NYSE on Friday.
Ginkgo Bioworks Going Public Through Merger With SPAC
The deal, which is expected to close in the third quarter of this year, implies a $15 billion pre-money equity valuation for Ginkgo.